have found that dexamethasone, an adjunctive therapy for TBM, could modulate the content of proinflammatory cytokines and chemokines secreted by the CNS macrophages while inhibiting the release of TNF and IL-6 in microglia (80). Here, TNF is linked to meningeal tuberculosis.